Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Tick-borne”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableUnknownNCT05607394
What this trial is testing

Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases

Who this might be right for
Tick-borne Encephalitis
University Hospital, Strasbourg, France 500
Testing effectiveness (Phase 2)Study completedNCT00161772
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Not applicableUnknownNCT02463942
What this trial is testing

Tick-borne Encephalitis and Positive Borrelial Antibodies

Who this might be right for
Tick-borne Encephalitis
University Medical Centre Ljubljana 100
Testing effectiveness (Phase 2)Study completedNCT00161798
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Post-approval studies (Phase 4)Study completedNCT00163540
What this trial is testing

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableStudy completedNCT03958058
What this trial is testing

Tick-borne Encephalitis and Possible Borrelial Serology

Who this might be right for
Tick Borne EncephalitisLyme Disease
University Medical Centre Ljubljana 690
Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Post-approval studies (Phase 4)Study completedNCT00161954
What this trial is testing

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Post-approval studies (Phase 4)UnknownNCT04573205
What this trial is testing

Primary TBE Vaccination for the Elderly

Who this might be right for
Tick-borne EncephalitisVaccine
Region Örebro County 90
Large-scale testing (Phase 3)Study completedNCT02318069
What this trial is testing

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 250
Testing effectiveness (Phase 2)Study completedNCT01991067
What this trial is testing

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 34
Testing effectiveness (Phase 2)UnknownNCT00890422
What this trial is testing

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

Who this might be right for
Tick Borne Encephalitis
Elisabethinen Hospital 99
Post-approval studies (Phase 4)Study completedNCT00311493
What this trial is testing

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Who this might be right for
Encephalitis, Tick-Borne
Novartis 179
Post-approval studies (Phase 4)Study completedNCT00161785
What this trial is testing

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer 340
Post-approval studies (Phase 4)UnknownNCT04017052
What this trial is testing

Application of a TBE-Vaccine in Obese Persons

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 73
Not applicableLooking for participantsNCT03418441
What this trial is testing

Central Nervous System Infections in Denmark

Who this might be right for
Central Nervous System InfectionsBacterial MeningitisViral Meningitis+9 more
Aalborg University Hospital 1,900
Large-scale testing (Phase 3)Study completedNCT00161746
What this trial is testing

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Post-approval studies (Phase 4)Study completedNCT00894686
What this trial is testing

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 179
Post-approval studies (Phase 4)Study completedNCT01106482
What this trial is testing

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Who this might be right for
Tick Borne Encephalitis (TBE)
Novartis Vaccines 126
Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Load More Results